47 results on '"Morra, Enrica"'
Search Results
2. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
3. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial
4. The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the “Rete Ematologica Lombarda”
5. Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3/NS4A inhibitor-based treatment. A case report
6. Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11–12, 2013
7. Corrigendum to ‘Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: The experience of the “Rete Ematologica Lombarda”’ [Leuk Res 37 (2013) 1233–1240]
8. Associated Cancers in Waldenström Macroglobulinemia: Clues for Common Genetic Predisposition
9. Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: The experience of the “Rete Ematologica Lombarda”
10. Should a Positive Direct Antiglobulin Test Be Considered a Prognostic Predictor in Chronic Lymphocytic Leukemia?
11. Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenström's Macroglobulinemia
12. Microarray Demonstrates Different Gene Expression Profiling Signatures Between Waldenström Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance
13. Regeneration-associated WNT Signaling Is Activated in Long-term Reconstituting AC133bright Acute Myeloid Leukemia Cells
14. Erythroleukemia presenting with myeloid sarcoma of the lung as detected by immunophenotypic analysis of bronchoalveolar lavage fluid
15. 4.4 ARSD Is a New Biomarker Associated with IgVH, ZAP-70, and Disease Progression in CLL
16. Plerixafor and G-CSF for PBSC mobilization in patients with lymphoma who failed previous attempts with G-CSF and chemotherapy: A REL (Rete Ematologica Lombarda) experience
17. Factors Predicting Transformation of Asymptomatic IgM Monoclonal Gammopathy
18. Report From the Sixth International Workshop on Waldenström's Macroglobulinemia
19. Down-regulation of MicroRNAs 222/221 in Acute Myelogenous Leukemia with Deranged Core-Binding Factor Subunits
20. Automated APTT cycle for the rapid identification of plasma prekallikrein deficiency
21. Flow cytometry vs cytomorphology for the detection of hematologic malignancy in body cavity fluids
22. Total serum tryptase: A predictive marker for KIT mutation in acute myeloid leukemia
23. Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects
24. Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia
25. Fludarabine-Based Combination Therapies for Waldenström's Macroglobulinemia
26. Prognostic value of circulating CD34+ cells in myelodysplastic syndromes
27. Outcome of hyperleukocytic adult acute myeloid leukaemia: A single-center retrospective study and review of literature
28. Cryoglobulinemia
29. Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia
30. STI 571 inhibition effect on KITAsn822Lys-mediated signal transduction cascade
31. The reply
32. Imatinib mesylate in the treatment of Core Binding Factor leukemias with KIT mutations
33. Clinical Characteristics and Outcome of Immunoglobulin M–Related Disorders
34. Prognostic Factors for Transformation in Asymptomatic Immunoglobulin M Monoclonal Gammopathies
35. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
36. Smouldering Waldenstrom's macroglobulinemia: Factors predicting evolution to symptomatic disease
37. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy
38. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
39. Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia
40. Is life expectancy of polycythemia vera patients clearly different from that of the general population?
41. Multicolor FISH in chronic lymphocytic leukemia. An interphase study of patients with early-onset disease
42. Treatment of patients with high-grade non-Hodgkin’s lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators
43. Trisomy 4 Leading to Duplication of a Mutated KIT Allele in Acute Myeloid Leukemia with Mast Cell Involvement
44. Mediastinal B-cell lymphoma: A study of its histomorphologic spectrum based on 109 cases
45. In VivoDifferentiation of Mast Cells from Acute Myeloid Leukemia Blasts Carrying a Novel Activating Ligand-Independent C-kit Mutation
46. Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemia
47. Risk of leukemia in patients treated for Hodgkin's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.